Evidence map›Paper›PMID 34853083›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

Hypocretin/Orexin Interactions with Norepinephrine Contribute to the Opiate Withdrawal Syndrome.

Ronald McGregor, Ming-Fung Wu, Brent Holmes, Hoa Anh Lam, Nigel T Maidment, Joseph Gera, Akihiro Yamanaka, Jerome M Siegel

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ronald McGregorDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90095 icelos3@gmail.com.
Ming-Fung WuDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90095.
Brent HolmesVeterans Administration Greater Los Angeles Healthcare System, North Hills, Los Angeles, California 91343.
Hoa Anh LamDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90095.
Nigel T MaidmentDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90095.
Joseph GeraVeterans Administration Greater Los Angeles Healthcare System, North Hills, Los Angeles, California 91343.ORCID 0000-0002-2908-6894
Akihiro YamanakaDepartment of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Nagoya 464-8601, Japan.ORCID 0000-0001-6099-7306
Jerome M SiegelDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California 90095.
University of California, Los Angeles · USNagoya University · JP

Funding

The Role of Striosome Neurons in Mediating Opiod RewardP50DA005010 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KENNEDY, PAMELA · 1987 to 2021
$30.7M
Role of hypocretin in opiate addiction and withdrawalR01DA034748 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SIEGEL, JEROME M · 2014 to 2024
$6.3M
Changes across the lifespan in the use of heuristics to guide decision-makingR01AG063090 · NIA · UNIVERSITY OF WASHINGTON · PI BASSO, MICHELE A · 2019 to 2023
$3.8M
Multi-organ-on-chip device for modeling opioid reinforcement and withdrawal, and the negative affective component of pain: a therapeutic screening tool.UG3TR003148 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ASHAMMAKHI, NUREDDIN, KHADEMHOSSEINI, ALI · 2019 to 2021
$2.1M
Co-targeting mTOR and YAP signaling in glioblastomaR01CA217820 · NCI · GREATER LOS ANGELES VETERANS RESEARCH AND EDUCATION FOUNDATION · PI GERA, JOSEPH F · 2018 to 2022
$1.6M
Mechanisms of Resistance to mTOR-Targeted TherapiesI01BX002665 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI GERA, JOSEPH F · 2014 to 2025
–
BLRD VA I01 BX002665NCATS NIH HHS UG3 TR003148NCI NIH HHS R01 CA217820NIA NIH HHS R01 AG063090NIDA NIH HHS P50 DA005010NIDA NIH HHS R01 DA034748
6 · The paper itself

Abstract

We previously found that human heroin addicts and mice chronically exposed to morphine exhibit a significant increase in the number of detected hypocretin/orexin (Hcrt)-producing neurons. However, it remains unknown how this increase affects target areas of the hypocretin system involved in opioid withdrawal, including norepinephrine containing structures locus coeruleus (LC) and A1/A2 medullary regions. Using a combination of immunohistochemical, biochemical, imaging, and behavioral techniques, we now show that the increase in detected hypocretin cell number translates into a significant increase in hypocretin innervation and tyrosine hydroxylase (TH) levels in the LC without affecting norepinephrine-containing neuronal cell number. We show that the increase in TH is completely dependent on Hcrt innervation. The A1/A2 regions were unaffected by morphine treatment. Manipulation of the Hcrt system may affect opioid addiction and withdrawal.

Indexed as

AnimalsLocus CoeruleusMiceMorphineMotor ActivityNeuronsNorepinephrineOpiate AlkaloidsOrexinsSubstance Withdrawal SyndromeTyrosine 3-MonooxygenaseMorphineNorepinephrineOpiate AlkaloidsOrexinsTyrosine 3-Monooxygenaseaddictionanatomyhypocretinlocus coeruleusopioidswithdrawal

Identifiers

PMID34853083
PMCPMC8802943
OpenAlexW3217663009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.